Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$32.85
-2.3%
$22.24
$6.27
$34.10
$976.87M2.541.24 million shs557,727 shs
Allient Inc. stock logo
ALNT
Allient
$45.46
-0.4%
$43.52
$16.91
$48.22
$769.65M1.51123,564 shs46,283 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$14.09
+5.2%
$11.56
$3.91
$14.42
$972.91M1.93809,750 shs248,295 shs
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$1.67
+4.1%
$1.35
$0.61
$5.77
$335.12M2.8511.37 million shs7.11 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
+3.38%+17.96%+85.80%+188.17%+174.31%
Allient Inc. stock logo
ALNT
Allient
-2.75%+0.84%-2.65%+30.31%+128.21%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+0.22%-1.54%+13.19%+27.04%+61.52%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-5.88%+20.30%+40.35%-20.79%+75.82%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$32.85
-2.3%
$22.24
$6.27
$34.10
$976.87M2.541.24 million shs557,727 shs
Allient Inc. stock logo
ALNT
Allient
$45.46
-0.4%
$43.52
$16.91
$48.22
$769.65M1.51123,564 shs46,283 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$14.09
+5.2%
$11.56
$3.91
$14.42
$972.91M1.93809,750 shs248,295 shs
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$1.67
+4.1%
$1.35
$0.61
$5.77
$335.12M2.8511.37 million shs7.11 million shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
+3.38%+17.96%+85.80%+188.17%+174.31%
Allient Inc. stock logo
ALNT
Allient
-2.75%+0.84%-2.65%+30.31%+128.21%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+0.22%-1.54%+13.19%+27.04%+61.52%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-5.88%+20.30%+40.35%-20.79%+75.82%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
0.00
N/AN/AN/A
Allient Inc. stock logo
ALNT
Allient
2.00
Hold$35.00-23.01% Downside
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$26.8690.61% Upside
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
2.67
Moderate Buy$3.48108.71% Upside

Current Analyst Ratings Breakdown

Latest QSI, AEHR, EYPT, and ALNT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2025
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$1.00
8/7/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Chardan Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$27.00
8/6/2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$22.00 ➝ $23.00
(Data available from 9/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$58.97M16.69$0.11 per share302.55$4.13 per share7.95
Allient Inc. stock logo
ALNT
Allient
$519.60M1.48$2.94 per share15.46$15.72 per share2.89
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$51.90M18.71N/AN/A$4.93 per share2.86
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
$3.06M110.18N/AN/A$1.29 per share1.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
-$3.91M-$0.13N/A149.31N/A-6.63%-0.15%-0.13%10/9/2025 (Estimated)
Allient Inc. stock logo
ALNT
Allient
$13.17M$0.8652.8124.84N/A2.75%9.97%4.67%11/5/2025 (Estimated)
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$130.87M-$2.68N/AN/AN/A-337.93%-63.80%-50.72%11/6/2025 (Estimated)
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$101.01M-$0.68N/AN/AN/A-3,120.14%-44.57%-39.45%11/11/2025 (Estimated)

Latest QSI, AEHR, EYPT, and ALNT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/9/2025Q1 2026
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
$0.01N/AN/AN/A$11.47 millionN/A
8/6/2025Q2 2025
Allient Inc. stock logo
ALNT
Allient
$0.48$0.57+$0.09$0.34$132.89 million$139.58 million
8/6/2025Q2 2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.67-$0.85-$0.18-$0.85$6.82 million$5.33 million
8/5/2025Q2 2025
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
-$0.16-$0.16N/A-$0.16$1.28 million$0.59 million
7/8/2025Q4 2025
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
-$0.02-$0.01+$0.01-$0.10$14.83 million$14.10 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/AN/AN/AN/AN/A
Allient Inc. stock logo
ALNT
Allient
$0.120.26%N/A13.95%N/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
N/AN/AN/AN/AN/A

Latest QSI, AEHR, EYPT, and ALNT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2025
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.3%8/21/20258/21/20259/4/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
N/A
5.68
2.99
Allient Inc. stock logo
ALNT
Allient
0.70
3.74
2.17
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
8.00
7.91
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
N/A
9.43
9.27

Institutional Ownership

CompanyInstitutional Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
69.69%
Allient Inc. stock logo
ALNT
Allient
61.57%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
39.90%

Insider Ownership

CompanyInsider Ownership
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
6.80%
Allient Inc. stock logo
ALNT
Allient
14.90%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
4.46%
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
22.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aehr Test Systems stock logo
AEHR
Aehr Test Systems
9029.97 million27.93 millionOptionable
Allient Inc. stock logo
ALNT
Allient
2,52516.95 million14.42 millionOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12068.93 million65.85 millionOptionable
Quantum-Si Incorporated stock logo
QSI
Quantum-Si
150202.49 million156.02 millionOptionable

Recent News About These Companies

Quantum-Si (NASDAQ:QSI) and Valens Semiconductor (NYSE:VLN) Head to Head Survey
Quantum-Si Updates Corporate Presentation on Growth
Quantum-Si (QSI) Q2 Revenue Falls 47%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aehr Test Systems stock logo

Aehr Test Systems NASDAQ:AEHR

$32.85 -0.78 (-2.32%)
As of 11:16 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.

Allient stock logo

Allient NASDAQ:ALNT

$45.46 -0.16 (-0.35%)
As of 11:15 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$14.09 +0.70 (+5.23%)
As of 11:16 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Quantum-Si stock logo

Quantum-Si NASDAQ:QSI

$1.66 +0.07 (+4.06%)
As of 11:16 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.